Form 8-K - Current report:
SEC Accession No. 0001860742-23-000012
Filing Date
2023-05-03
Accepted
2023-05-03 07:06:41
Documents
14
Period of Report
2023-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blco-20230503.htm   iXBRL 8-K 36900
2 EX-99.1 ex991q1-2023.htm EX-99.1 300350
6 BL LOGO bllogo-hiresa.jpg GRAPHIC 223158
  Complete submission text file 0001860742-23-000012.txt   805430

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blco-20230503.xsd EX-101.SCH 1893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blco-20230503_lab.xml EX-101.LAB 24791
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blco-20230503_pre.xml EX-101.PRE 13028
8 EXTRACTED XBRL INSTANCE DOCUMENT blco-20230503_htm.xml XML 11038
Mailing Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4
Business Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 908-541-5456
Bausch & Lomb Corp (Filer) CIK: 0001860742 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41380 | Film No.: 23881638
SIC: 3851 Ophthalmic Goods